Jul 16, 2024 | 2024, Past Events
Prof. Dr. Dario Neri, Philogen’s CEO and CSO, is giving a lecture entitled “Antibody-Cytokine Fusion Proteins for Cancer Therapy: Late-Stage Clinical Results” Dr. Samuele Cazzamalli, Philogen Head of Small Molecule Therapeutics is giving a presentation...Jul 9, 2024 | 2024, Investors, Past Events
Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024. Please contact us at IR@philogen.com or follow the link register to the event.Jul 4, 2024 | 2024, Investors, Press Releases
For more detailsJun 4, 2024 | 2024, Press Releases, Scientific
more detailsJun 4, 2024 | 2024, Press Releases, Scientific
more detailsMay 31, 2024 | 2024, Press Releases
More details
Recent Comments